Nov 26, 2014 05:08PM
Nov 26, 2014 05:00PM
Nov 26, 2014 11:35AM
Nov 21, 2014 08:34AM
Nov 21, 2014 08:07AM
Nov 19, 2014 08:32AM
Nov 19, 2014 08:13AM Clovis Oncology (CLVS) Poised to Open Lower; Interim Data from CO-1686 Phase 1/2 Shows 67% Objective Response Rate
Nov 19, 2014 08:09AM
Nov 18, 2014 06:28AM
Nov 17, 2014 05:39PM
Nov 14, 2014 03:38PM
Nov 13, 2014 04:14PM
Nov 11, 2014 04:15PM
Nov 11, 2014 08:52AM Threshold Pharma (THLD) TH-302 Receives FDA Fast Track Designation
Nov 10, 2014 08:16AM
Nov 7, 2014 08:37AM
Nov 6, 2014 06:57PM
Nov 6, 2014 04:49PM
Nov 6, 2014 04:20PM
Nov 6, 2014 07:02AM
Nov 4, 2014 04:21PM Exelixis, Inc. (EXEL) Reports Top-Line Results From a Phase 2 Trial of Cabozantinib
Nov 4, 2014 08:11AM
Nov 3, 2014 08:19AM
Oct 31, 2014 07:29AM
Oct 30, 2014 08:56AM
Oct 27, 2014 04:22PM
Oct 27, 2014 04:10PM
Oct 27, 2014 08:01AM Akebia Therapeutics (AKBA) Phase 2b Study of AKB-6548 Meets Primary Endpoint
Oct 27, 2014 07:05AM
Oct 23, 2014 09:08AM
Oct 21, 2014 04:48PM
Oct 21, 2014 04:18PM
Oct 21, 2014 03:19PM
Oct 17, 2014 07:20AM
Oct 16, 2014 09:34AM Diplomat Pharmacy (DPLO) Reports FDA Approval Under 'Breakthrough Status'
Oct 15, 2014 04:45PM
Oct 10, 2014 01:37PM
Oct 7, 2014 08:37AM
Oct 6, 2014 08:05AM
Sep 29, 2014 06:00PM
Sep 29, 2014 08:08AM
Sep 29, 2014 07:58AM EnteroMedics' (ETRM) Maestro Awarded CE Mark for Type 2 Diabetes
Sep 26, 2014 04:12PM
Sep 26, 2014 03:49PM
Sep 26, 2014 03:49PM
Sep 24, 2014 08:35AM
Sep 22, 2014 08:21AM
Sep 18, 2014 06:02AM
Sep 17, 2014 04:35PM FDA Votes to Revise Current Indications for Testosterone Therapy
Sep 17, 2014 04:09PM

438 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving Hot FDA News reports.